REFERENCES
- Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010; 303(20):2043–2050.
- Mori H, Ukai H, Yamamoto H, Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29(3):143–151.
- Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23(8):1296–1310.
- Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20(10):1512–1517.
- Wu JY, Leung WY, Chang S, Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333(7567):522.
- Bangalore S, Ley L. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations. Expert Opin Pharmacother 2012; 13(3):345–355.
- Hermida RC, Ayala DE, Calvo C, Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 2005; 46(4):1053–1059.
- Ogihara T, Kikuchi K, Matsuoka H, ; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32(1):3–107.
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55(2):399–407.
- Krause T, Lovibond K, Caulfield M, McCormack T, Williams B; Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ 2011; 25(343):d4891.
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5):487–497.
- Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980; 2(6):757–764.
- Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12(3):239–245.